| 3 / 3 | Ongoing research grants |
| 27 / 17 | Completed research grants |
| 4 / 4 | Ongoing scholarships in Brazil |
| 68 / 28 | Completed scholarships in Brazil |
| 9 / 7 | Completed scholarships abroad |
| 111 / 59 | All research grants and scholarships |
| Associated processes | |
Send your message by email
Advanced search
Luis Carlos de Souza Ferreira
CV Lattes
ResearcherID
ORCID
PLATAFORMA CIENTIFICA PASTEUR USP/USP (Institutional affiliation for the last research proposal) Birthplace: Brazil
Graduated in Biological Sciences from the Federal University of Rio de Janeiro (1978), Master's degree in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1982) and PhD in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1985) ). Conducted postdoctoral internships at the Max-Planck Institute in Tuebingen, Germany (1986/7), Vaccine Development Center at the University of Maryland, USA (1991), Department of Microbiology and Molecular Biology, Tufts University, USA (1992 ) and Department of Medical Microbiology at the University of Gothenburg, Sweden (1996). Visiting researcher at the Institute of Genetics, University of Bayreuth, Germany (2000-2005). Adjunct professor at the Biophysics and Radiobiology Department at the Federal University of Pernambuco (1983-1989) and at the Carlos Chagas Filho Biophysics Institute at the Federal University of Rio de Janeiro (1989-2000). He is currently a full professor (1999) and a full professor (2000) at the University of São Paulo and responsible for the Vaccine Development Laboratory in the Department of Microbiology at the Institute of Biomedical Sciences. Researcher 1A of the National Council for Scientific and Technological Development (until 2023). Coordinator of the Vaccine Research Support Center at USP. Vice-director of the USP Biomedical Sciences Institute (2013-2017). Director of the USP Biomedical Sciences Institute (2017-2021). Coordinator of the Scientific Platform Pasteur-USP (2018-2022). He received several awards related to scientific work and technological innovation. He has experience in the areas of Microbiology, Molecular Genetics and Microorganisms, immunology and vaccine development. He works on research related to the development of different vaccine strategies, among them research on vaccines aimed at controlling diarrhea caused by enteric bacteria (diarrhogenic Escherichia coli), dengue, dental caries and tumors induced by papillomavirus. He also conducts research related to the development of new vaccine adjuvants of a microbial nature. He develops projects in partnership with companies such as GSK, Instituto Butantan and Fundação Oswaldo Cruz. He has published about 200 scientific articles in specialized journals and has 9 patent applications filed with the INPI and / or PCT. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Standing alone |
| Para caminar por sus propios medios |
| Avanza el coronavirus en Brasil |
| A villain with many faces |
| Un villano con muchas caras |
| A villain with many faces |
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| FAPESP-funded startups are developing COVID-19 vaccines |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Research grants
- Obtaining and validating immunobiologicals for the specific diagnosis and sorotyping of dengue, AP.PIPE
- Challenges in the control of emerging diseases and resistance in pathogens and vectors, AO.R
- Antigen targeting to dendritic cells as a strategy to improve the efficiency of immunotherapies to HPV-16-associated tumors., AP.R
(Only some records are available in English at this moment)
Scholarships in Brazil
- Active immunotherapy based on dendritic cells combined with chemotherapy in the treatment of advanced tumors associated with HPV-16, BP.DR
- Development of self assembling protein nanovaccines based on the spike protein of SARS-CoV-2 for induction of humoral response in a murine model, BP.IC
- Development os SAPN nanovaccines against SARS-CoV-2 using S and N as antigens, BP.PD
(Only some records are available in English at this moment)
- Antigen discovery and development of serological diagnostic methods and vaccine approaches against the zika virus (ZIKV), BP.TT
- Antigen Discovery and development of serological diagnostic methods and vaccine approaches against the zika virus (ZIKV), BP.TT
- Nanovaccines: a novel experimental concept applied to the development of subunit vacines., BP.PD
(Only some records are available in English at this moment)
Scholarships abroad
- A novel nanoparticle-based vaccine against SARS-CoV-2 assembled on a nanomimetic amyloid for controlled antigen release, BE.EP.PD
- Identification and characterization of peptides capable to interfere with the infection mechanisms of dengue and zika viruses, BE.EP.DR
- mRNA-based vaccines targeting HPV-induced tumors, BE.EP.DR
(Only some records are available in English at this moment)
Total / Available in English